From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement on July 9, 2026 Posted by
Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch on July 9, 2026 Posted by
The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health on July 9, 2026 Posted by
Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’ on July 9, 2026 Posted by
Scaling the Silence: Ognomy Secures $20 Million to Transform the Future of Sleep Medicine on July 9, 2026 Posted by
The End of "Always-On": New Moisture-Activated Battery Serves as a Physical Kill Switch for IoT Surveillance on July 9, 2026 Posted by
Pearl Health Secures $110 Million to Scale AI-Driven Value-Based Care Revolution on July 9, 2026 Posted by
From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement on July 9, 2026 Posted by
Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch on July 9, 2026 Posted by
The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health on July 9, 2026 Posted by
Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’ on July 9, 2026 Posted by
Posted in Digital Health Tools Beyond Compliance: Why Pharma Must Pivot from Monitoring to Mining User-Generated Content on May 12, 2026 rifanmuazin
Posted in Digital Health Tools Angelini Pharma’s $4.1 Billion Strategic Leap: A New Chapter in Global Rare Disease Treatment on May 10, 2026 rifanmuazin
Posted in Medical Innovations Angelini Pharma Expands U.S. Footprint with $4.1 Billion Acquisition of Catalyst Pharmaceuticals on May 9, 2026 rifanmuazin
Posted in Medical Innovations The 2026 Pharma M&A Surge: A Strategic Response to the Looming Patent Cliff on May 9, 2026 rifanmuazin
